상처 치료를 위한 생물학적 요법 : 기술 및 세계 시장

The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.

The North American market for wound care biologics is expected to grow from $3.1 billion in 2025 and is projected to reach $4.7 billion by the end of 2030, at a CAGR of 9% during the forecast period of 2025 to 2030.

The European market for wound care biologics is expected to grow from $2.2 billion in 2025 and is projected to reach $3.4 billion by the end of 2030, at a CAGR of 8.7% during the forecast period of 2025 to 2030.

Report Scope

The global wound care biologics report provides an overview and analyzes market trends. The report includes global revenue ($ million) for the base year data (2024) and estimated data for the forecast period (2025 through 2030). The market is segmented by product type, application, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the World (RoW), with a focus on major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, including rankings of key companies in the global wound care biologics market. It also features a dedicated section of company profiles that covers details such as overview, key financials, product portfolio, and recent developments of key companies.

Report Includes

• 78 data tables and 61 additional tables
• Overview and an analysis of the global market for wound care biologics and related technologies
• Analyses of the global market trends, with historic data from 2022 to 2025, and projections of CAGRs through 2030
• Estimates of the market size and revenue prospects for the global market, accompanied by a market share analysis by product type, application, end user, and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Profiles of the leading global companies, including Convatec Group PLC., Integra LifeSciences Corp., MIMEDX Group Inc., and Organogenesis Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• History of Wound Care
• Technology Background
• Types of Wounds
• Wound Healing Process
• Hemostasis
• Inflammation
• Proliferation
• Maturation or Remodeling
• ECM Composition and Its Importance in Skin Wound Healing
• Biologic Therapies for Wound Care
• Autologous
• Allogeneic
• Heterologous/Xenogenic
• Macroeconomic Factors Analysis
• PESTEL Analysis
• Impact of U.S. Tariff Laws on the Wound Care Biologics Market
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate to High)
• Bargaining Power of Buyers (High)
• Threat of Substitutes (High)
• Competition in the Industry (High)

Chapter 3 Market Dynamics

• Market Drivers
• Growing Geriatric Population
• Increasing Prevalence of Diabetes and Target Conditions
• Increasing Incidence of Burn Injuries
• Innovations in Wound Care Biologics
• Market Restraints
• High Cost and Lack of Skilled Workforce
• Unfavorable Reimbursement Scenario
• Complex Regulatory Framework
• Market Opportunities
• Growing Industry Collaborations in Wound Care Biologics Market
• Growth Opportunities in Emerging Markets

Chapter 4 Regulatory Landscape

• FDA Regulatory Review and Approval Process
• Premarket Approval (PMA)
• 510(k) Clearance
• Biologics License Application
• Human Cells, Tissues, and Cellular and Tissue-based Products (HCT/Ps)
• Coverage and Reimbursement
• Medicare Coverage
• Medicaid
• Private Payers

Chapter 5 Emerging Technologies and New Developments

• Overview
• Smart Dressings and Bioactive Nanomaterials
• 3D Bioprinting
• Artificial Intelligence (AI) in Wound Care Biologics

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product Type
• Key Takeaways
• Cellular and Tissue-Based Products (CTPs)/Skin Substitutes
• Acellular CTPs
• Cellular CTPs
• Biologic Skin Substitute
• Bioengineered Skin Substitutes
• Topical Agents
• Keratin Proteins
• Enzymatic Debridement Agents
• Market Breakdown by Application
• Key Takeaways
• Chronic Wounds
• Acute Wounds
• Market Breakdown by End User
• Key Takeaways
• Ambulatory Surgery Centers (ASCs)
• Hospitals
• Burn Care Centers and Wound Clinics
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Top Companies Ranking in Wound Care Biologics Market, 2024
• Key Companies by Product Type
• Allografts
• Acellular Animal-Derived Tissue-Based Products/Xenografts
• Strategic Analysis

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• ABBVIE INC.
• AROA BIOSURGERY LTD.
• BIOTISSUE
• BIOVENTUS
• CELLUTION BIOLOGICS INC.
• CONVATEC GROUP PLC
• ELUTIA
• FIBROHEAL
• INTEGRA LIFESCIENCES CORP.
• JOHNSON & JOHNSON
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SKYE BIOLOGICS HOLDINGS LLC.
• SMITH + NEPHEW
• STRYKER
• ZIMMER BIOMET